Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advisory Board Co (NASDAQ:ABCO)

44.70
Delayed Data
As of Mar 24
 0.00 / 0.00%
Today’s Change
24.85
Today|||52-Week Range
51.23
+34.44%
Year-to-Date
Allergan's Restasis Now Available in Multidose Bottle in U.S.
Mar 23 / Zacks.com - Paid Partner Content
Jazz Initiates Phase III Study for Narcolepsy Candidate
Mar 16 / Zacks.com - Paid Partner Content
Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study
Mar 23 / Zacks.com - Paid Partner Content
AstraZeneca's Cancer Drug Lynparza Positive in Phase III
Mar 15 / Zacks.com - Paid Partner Content
Advent International Corp Buys Stericycle, The Advisory Board Co, Sells Bojangles, Ac...
Mar 23 / GuruFocus News - Paid Partner Content
Arena Pharmaceuticals (ARNA) Posts Q4 Earnings, Revenues Up
Mar 15 / Zacks.com - Paid Partner Content
Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down
Mar 22 / Zacks.com - Paid Partner Content
Community Health Continues Divestiture, to Sell 4 Hospitals
Mar 15 / Zacks.com - Paid Partner Content
Jazz Sleep Disorder Drug Positive in Phase III Studies
Mar 21 / Zacks.com - Paid Partner Content
Teladoc Continues to Grow in Booming Telehealth Industry
Mar 14 / Zacks.com - Paid Partner Content
Teva Launches Authorized Generic of Allergan's Minastrin
Mar 17 / Zacks.com - Paid Partner Content